» Authors » Hamdi Mbarek

Hamdi Mbarek

Explore the profile of Hamdi Mbarek including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 77
Citations 4344
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Smatti M, Yassine H, Mbarek H, Boomsma D
Genes (Basel) . 2025 Feb; 16(2). PMID: 40004506
Genetic factors have been hypothesized to contribute to the heterogeneity in the response to infectious diseases (IDs). The classical twin design provides a powerful tool to estimate the role of...
2.
Bejaoui Y, Srour L, Qannan A, Oshima J, Saad C, Horvath S, et al.
Geroscience . 2025 Feb; PMID: 39928272
Several progeroid syndromes' causative mutations have been linked to epigenetic age acceleration as measured via several epigenetic clocks. At the same time, several protective variants have also been discovered that...
3.
Szenker-Ravi E, Ott T, Yusof A, Chopra M, Khatoo M, Pak B, et al.
Am J Hum Genet . 2025 Jan; 112(2):353-373. PMID: 39753129
Four genes-DAND5, PKD1L1, MMP21, and CIROP-form a genetic module that has specifically evolved in vertebrate species that harbor motile cilia in their left-right organizer (LRO). We find here that CIROZ...
4.
Ben-Mahmoud A, Gupta V, Abdelaleem A, Thompson R, Aden A, Mbarek H, et al.
Int J Mol Sci . 2024 Nov; 25(21). PMID: 39519104
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by deficits in social communication, restricted interests, and repetitive behaviors. Despite considerable research efforts, the genetic complexity of ASD remains poorly...
5.
German J, Cordioli M, Tozzo V, Urbut S, Arumae K, Smit R, et al.
medRxiv . 2024 Sep; PMID: 39314946
Obesity is a significant public health concern. GLP-1 receptor agonists (GLP1-RA), predominantly in use as a type 2 diabetes treatment, are a promising pharmacological approach for weight loss, while bariatric...
6.
Devadoss Gandhi G, Aliyev E, Syed N, Vempalli F, Saad C, Mbarek H, et al.
Genet Med . 2024 Sep; 26(12):101268. PMID: 39286960
Purpose: To date, approximately 1400 inherited metabolic disorders (IMDs) have been described, some of which are treatable. It is estimated that 2% to 3% of live births worldwide are affected...
7.
Elfatih A, Saad C, Mifsud B, Mbarek H
Eur J Hum Genet . 2024 Jul; 32(11):1465-1473. PMID: 39020067
Arabic populations are underrepresented in large genome projects; therefore, the frequency of clinically actionable variants among Arabs is largely unknown. Here, we investigated genetic variation in 14,392 whole genomes from...
8.
Khabou B, Sahari U, Ben Issa A, Bouchaala W, Szenker-Ravi E, Ng A, et al.
J Hum Genet . 2024 Jul; 69(11):591-597. PMID: 38987656
The clinical diagnosis of patients with multisystem involvement including a pronounced neurologic damage is challenging. High-throughput sequencing methods remains crucial to provide an accurate diagnosis. In this study, we reported...
9.
Abdel-Latif R, Badji R, Mohammed S, Al-Muftah W, Mbarek H, Darwish D, et al.
Clin Transl Sci . 2024 May; 17(6):e13800. PMID: 38818903
Pharmacogenetic (PGx)-informed medication prescription is a cutting-edge genomic application in contemporary medicine, offering the potential to overcome the conventional "trial-and-error" approach in drug prescription. The ability to use an individual's...
10.
Bastaki K, Velayutham D, Irfan A, Adnan M, Mohammed S, Mbarek H, et al.
Front Public Health . 2024 Mar; 12:1364221. PMID: 38550311
Pharmacogenomics (PGx) is an important component of precision medicine that promises tailored treatment approaches based on an individual's genetic information. Exploring the initiatives in research that help to integrate PGx...